Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1549-1554

  Magge, Sheela N ^a,c   Stettler, Nicolas ^a,c   Koren, Dorit ^a   Levitt Katz, Lorraine E ^a,c   Gallagher, Paul R ^a   Mohler III, Emile R ^b,c   Rader, Daniel J ^b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; ATHEROGENESIS; BODY MASS; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OBESITY;

EID: 79955662236     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2364     Document Type: Article

References (25)

1. Liese AD, D'Agostino Jr RB, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE 2006 The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118:1510-1518 (Pubitemid 46393797)
2. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N 2004 Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110:2494-2497 (Pubitemid 39407358)
3. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS 2005 A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138-1145 (Pubitemid 40365358)
4. Goldstein BJ, Scalia R 2004 Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89: 2563-2568 (Pubitemid 38766332)
5. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228 (Pubitemid 36126226)
6. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y 2003 Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89 (Pubitemid 36091630)
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599 (Pubitemid 30353893)
8. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374 (Pubitemid 38702847)
9. Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, Tamborlane WV, Dziura J, Shulman GI, Caprio S 2005 The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 90:3731-3737 (Pubitemid 41014349)
10. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer- Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
11. Kim KY, Kim JK, Han SH, Lim JS, Kim KI, Cho DH, Lee MS, Lee JH, Yoon DY, Yoon SR, Chung JW, Choi I, Kim E, Yang Y 2006 Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 176:5958-5964
12. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ 2003 Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026 (Pubitemid 37377262)
13. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ 2006 Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17:2599-2606 (Pubitemid 44300977)
14. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Saito M, Momomura S, Ishikawa SE 2006 Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 70:1557-1562 (Pubitemid 44819870)
15. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y 2003 Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453-462 (Pubitemid 36173203)
16. Austin MA, King MC, Vranizan KM, Krauss RM 1990 Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506
17. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA 1998 Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18:1046-1053 (Pubitemid 28323588)
18. Kazumi T, Kawaguchi A, Hirano T, Yoshino G 2004 Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 53:589-593 (Pubitemid 38596530)
19. Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, Kark JD 2009 Adiponectin and lipoprotein particle size. Diabetes Care 32:1317-1319
20. Pérez-Méndez O, Torres-Tamayo M, Posadas-Romero C, Vidaure Garcés V, Carreón-Torres E, Mendoza-Pérez E, Medina Urrutia A, Huesca-Gómez C, Zamora-González J, Aguilar-Herrera B 2007 Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus. Clin Chim Acta 376:17-22 (Pubitemid 44880974)
21. Freedman DS, Bowman BA, Otvos JD, Srinivasan SR, Berenson GS 2000 Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study. Atherosclerosis 152: 441-449
22. Burns SF, Lee S, Arslanian SA 2009 In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care 32:2087-2093
23. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV 1989 Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114:963-967 (Pubitemid 19151751)
24. Kimm SY, Glynn NW, Kriska AM, Barton BA, Kronsberg SS, Daniels SR, Crawford PB, Sabry ZI, Liu K 2002 Decline in physical activity in black girls and white girls during adolescence. N Engl J Med 347:709-715 (Pubitemid 35203901)
25. Cavadini C, Siega-Riz AM, Popkin BM 2000 US adolescent food intake trends from 1965 to 1996. Arch Dis Childhood [Erratum (2002) 87:85] 83:18-24